← New search
Phenotype profile

inflammatory bowel disease

SaudiVarKB evidence summary derived from retained literature mentions.

691Phenotype mentions
100Publications
50Associated gene records
34Associated variant records

Associated gene records

Co-mentioned in the same publications
GeneIdentifier / contextArticlesMentions
TLR4HGNC:118501010
STAT3HGNC:1136477
NLRP3HGNC:1640066
SIRT1HGNC:1492955
RIPK1HGNC:1001944
NOD2HGNC:533144
HMGB1HGNC:498344
MPOHGNC:721833
IL10HGNC:596233
EGFRHGNC:323633
BAXHGNC:95933
TYK2HGNC:1244022
BCL2HGNC:99022
CARMIL2HGNC:2708922
LRRK2HGNC:1861822
ABCB1HGNC:4022
LDLRHGNC:654722
JAK2HGNC:619222
CD44HGNC:168122
CD28HGNC:165322
NCF2HGNC:766122
CD200R1HGNC:2423522
TPMTHGNC:1201422
TFAMHGNC:1174122
MUC2HGNC:751222
DLG5HGNC:290422
CPT1AHGNC:232811
PAHHGNC:858211
COL1A1HGNC:219711
TNFHGNC:1189211
APOEHGNC:61311
ATF6HGNC:79111
VWFHGNC:1272611
CD40HGNC:1191911
TBX4HGNC:1160311
G6PDHGNC:405711
CFTRHGNC:188411
CASTHGNC:151511
CRPHGNC:236711
SQSTM1HGNC:1128011
AGLHGNC:32111
CYP3A4HGNC:263711
BRAFHGNC:109711
CXCL8HGNC:602511
AKT1HGNC:39111
MALAT1HGNC:2966511
S100A9HGNC:1049911
IMPACTHGNC:2038711
TFHGNC:1174011
VDRHGNC:1267911

Associated variant records

Co-mentioned in the same publications
VariantIdentifier / contextArticlesMentions
Q53LQ53L11
Y99NY99N11
W351GW351G11
D365AD365A11
Q376HQ376H11
V25IV25I11
W100GW100G11
rs6505162rs650516211
rs7975232rs797523211
rs1544410rs154441011
rs731236rs73123611
p.W577Cp.W577C11
G894TG894T11
rs2228570rs222857011
C1672TC1672T11
G113AG113A11
C4136AC4136A11
rs1799964rs179996411
rs1050152rs105015211
G58VG58V11
G313VG313V11
c.855_856delc.855_856del11
rs992157rs99215711
rs2382817rs238281711
C3435TC3435T11
rs3810936rs381093611
rs7848647rs784864711
rs6478108rs647810811
W69GW69G11
p.T84Ip.T84I11
p.Y91Cp.Y91C11
p.R101Wp.R101W11
p.R117Cp.R117C11
p.R117Hp.R117H11

Associated population records

Co-mentioned in the same publications
PopulationIdentifier / contextArticlesMentions
Saudi Arabia4949
Population recordCohort 10055
Population recordCohort 1744
Population recordCohort 1944
Population recordCohort 544
Saudi Arabia33
Population record33
Population recordCohort 2433
Population recordCohort 4033
Population recordCohort 233
Saudi Arabia · Jeddah33
Saudi Arabia · RiyadhCohort 5033
Population recordCohort 3533
Saudi ArabiaCohort 37433
Saudi Arabia · RiyadhCohort 15833
Population recordCohort 28433
Population recordCohort 722
Saudi Arabia · Riyadh22
Population recordCohort 8022
Population recordCohort 6022
Saudi ArabiaCohort 1622
Saudi ArabiaCohort 3622
Saudi Arabia · Qassim22
Population recordCohort 4622
Population recordCohort 8922
Saudi ArabiaCohort 14522
Saudi Arabia · Makkah22
Population recordCohort 19822
Saudi ArabiaCohort 96022
Saudi ArabiaCohort 63022
Population recordCohort 29022
Population recordCohort 2,01422
Population recordCohort 6511
Saudi ArabiaCohort 1011
Population recordCohort 1311
Population recordCohort 1411
Saudi ArabiaCohort 1111
Saudi ArabiaCohort 8711
Saudi ArabiaCohort 211
Saudi ArabiaCohort 7111
Population recordCohort 7211
Saudi ArabiaCohort 34011
Population recordCohort 11911
Population recordCohort 9511
Saudi ArabiaCohort 511
Population recordCohort 8711
Population recordCohort 15411
Saudi Arabia · RiyadhCohort 3011
Population recordCohort 13011
Population recordCohort 20011

Supporting publications

100 records
  1. 2026AQP9 and IFITM1 as drivers of immune infiltration and tumor progression in IBD-associated colorectal cancer: from computational insights to experimental validation.Naunyn-Schmiedeberg's archives of pharmacology1 mentions
  2. 2026Ultraprocessed Grains and Risk of Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology Study.The American journal of gastroenterology1 mentions
  3. 2026A Review on Functional Foods Regulate the Gut Microbiota and Mast Cell Function in Inflammatory Bowel Disease (IBD).Probiotics and antimicrobial proteins1 mentions
  4. 2026Frequency of thiopurine methyltransferase variants and exploratory predictors of azathioprine-induced leukopenia in Saudi patients with inflammatory bowel disease.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  5. 2026Cost calculation model of introducing Upadacitinib and Risankizumab for adult ulcerative colitis and Crohn's disease in the Kingdom of Saudi Arabia.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  6. 2026Patterns and predictors of biologic therapy switching in inflammatory bowel disease at a tertiary care center: A retrospective observational study.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  7. 2026The Impact of Disease Activity and Medications on Pregnancy and Fetal Outcomes in Women With Inflammatory Bowel Disease: A Cohort Study From the IBD-ME Group.Journal of gastroenterology and hepatology1 mentions
  8. 2026Evaluation of 1H-pyrazol-1-yl benzenesulfonamide derivatives in alleviating inflammatory bowel disease via PI3K/Akt/mTOR signaling pathway in zebrafish models.Naunyn-Schmiedeberg's archives of pharmacology1 mentions
  9. 2026Inflammatory Bowel Disease in Children and Young People Living With Overweight or Obesity: A Critical Narrative Review.Obesity reviews : an official journal of the International Association for the Study of Obesity1 mentions
  10. 2026The melatonin-microbiome axis: a new frontier in gut health for the immunomodulatory, antioxidant and anti-inflammatory properties.Inflammopharmacology1 mentions
  11. 2026Practical guidelines on medical management of adults with moderate-to-severe inflammatory bowel disease.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  12. 2026Unlocking potentials of a prenylated flavonoid: Xanthohumol's role in combating inflammatory conditions and Rhematic diseases.Cytokine1 mentions
  13. 2026Protective Effects of Herbacetin in Experimental Colitis: Targeting NF-κB and NLRP3 Pathways.Drug development research1 mentions
  14. 2026Modulation of Inflammatory and Apoptotic Pathways by Tamarix Aphylla Essential Oil in TNBS-Induced Colitis: A Focus on Cytokine Balancing, NF-κB, p38 MAPK, and Nrf2 Activation.Applied biochemistry and biotechnology1 mentions
  15. 2026Effectiveness and safety of upadacitinib in refractory pediatric inflammatory bowel disease: A single-arm meta-analysis of observational studies.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  16. 2026The efficacy of adipose-derived stem cell therapy for complex perianal fistulas in Crohn's disease patients: A systematic review.Surgery open science1 mentions
  17. 2026A Mangifera indica L. extract functions as a broad TLR2/4/6 signalling rheostat to attenuate MyD88/NF-κB-driven inflammation and macrophage polarization.Pharmacological research1 mentions
  18. 2026Digital horizons: Exploring the future of AI-enabled gastroenterology in the Kingdom of Saudi Arabia.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  19. 2026Investigating therapeutic efficacy of Lactobacillus salivarius GZLC1 on colitis by examining its effects on intestinal fungi, antioxidant capacity, and inflammatory response in mice.Beneficial microbes1 mentions
  20. 2026Co-Occurrence of Inflammatory Bowel Disease in Patients with Vitiligo: A Systematic Review and Meta-Analysis.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology1 mentions
  21. 2026Association between spicy food consumption and inflammatory bowel disease: A case-control study from Saudi Arabia.Nutrition (Burbank, Los Angeles County, Calif.)1 mentions
  22. 2026Liposomal amphotericin B in the treatment of pediatric gastrointestinal basidiobolomycosis.Journal of medical case reports1 mentions
  23. 2026Optimizing vedolizumab therapy in ulcerative colitis: A critical synthesis of trial evidence and the emerging role of artificial intelligence.PLOS digital health1 mentions
  24. 2026Redrawing the gut map: evolving probiotic approaches to microbiota modulation in inflammatory bowel disease.Antonie van Leeuwenhoek1 mentions
  25. 2026Advanced therapies for inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and meta-analysis.Inflammatory bowel diseases1 mentions
  26. 2026Prevalence and Clinical Correlates of Fibromyalgia Screening Positivity in Patients with Inflammatory Bowel Disease.Journal of clinical medicine1 mentions
  27. 2026Diagnostic challenges and treatment approaches for Clostridioides difficile infection in IBD patients.Frontiers in microbiology1 mentions
  28. 2026Repurposing alogliptin for ulcerative colitis: involvement of MicroRNAs, anti-inflammatory, and barrier-restoring mechanisms.Naunyn-Schmiedeberg's archives of pharmacology1 mentions
  29. 2026Confocal Laser Endomicroscopy: Real-Time Histology at the Fingertips: A Comprehensive Review of Current Applications of Endomicroscopy in Barrett Esophagus, Inflammatory Bowel Disease, and Colorectal Lesions.Medicina (Kaunas, Lithuania)1 mentions
  30. 2026Ulcerative colitis, pathophysiological mechanisms and drug repurposing: a new therapeutic dawn-narrative review.Inflammopharmacology1 mentions
  31. 2026Mirikizumab four-year sustained and durable efficacy and safety in ulcerative colitis: Final findings from the LUCENT-3 open-label extension study.Inflammatory bowel diseases1 mentions
  32. 2026Incidence of acne in patients with inflammatory bowel disease treated with Janus kinase inhibitors: a systematic review and meta-analysis.Inflammatory bowel diseases1 mentions
  33. 2026Association Between Ultraprocessed Food Intake and Inflammatory Bowel Disease Risk: A Propensity-Matched Analysis With Monte Carlo Simulation From the Prospective Urban Rural Epidemiology Study.Gastroenterology1 mentions
  34. 2026Accelerated Muscle Strength Decline and Reduced Lean Mass in Adults with Treated Inflammatory Bowel Disease: A NHANES Study.Journal of lifestyle medicine1 mentions
  35. 2026Comparing the pharmacokinetics of adalimumab originator and biosimilar product in patients with Inflammatory bowel disease or autoimmune disease.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society1 mentions
  36. 2026Immunoinformatic-based design of a multi-epitope subunit vaccine against Ruminococcus torques using subtractive proteomics and molecular dynamics simulations.Scientific reports1 mentions
  37. 2026Characteristics, Complications, Comorbidities, and Other Manifestations of Inflammatory Bowel Disease: A 7-Year Tertiary Center Experience.Clinics and practice1 mentions
  38. 2026STING pathway contributes to Steroid-Hyporesponsive Lung Inflammation in DSS-induced colitis mice model.PloS one1 mentions
  39. 2026Clinical consequences of delayed recognition of gastrointestinal basidiobolomycosis: a case series.Journal of surgical case reports1 mentions
  40. 2026Colon-targeted pH-responsive tofacitinib beads improve ulcerative colitis outcomes with lower systemic exposure.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society1 mentions
  41. 2026Bacterial and fungal biomarkers in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): trans-kingdom interactions, Blastocystis carriage, and enterotype-succinotype stratification.Gut pathogens1 mentions
  42. 2026Harnessing Nanocarriers to Modulate Gut Inflammation: A New Era in IBD Management.Recent advances in inflammation & allergy drug discovery1 mentions
  43. 2026Marine algal TNF-α inhibitors explored by comparative docking and molecular dynamics simulations.Computational biology and chemistry1 mentions
  44. 2026Correction: A Cross-Sectional Study on Pediatric Resident Knowledge and Perceptions of Irritable Bowel Syndrome and Inflammatory Bowel Disease in Western Saudi Arabia.Cureus1 mentions
  45. 2026Self-Management Interventions in Young Adults (18-30 Years) With Type 1 Diabetes, Sickle Cell Disease, and Inflammatory Bowel Disease: A Scoping Review.Chronic diseases and translational medicine1 mentions
  46. 2026Mode of birth and risk of inflammatory bowel disease in offspring: an updated systematic review and meta-analysis.Frontiers in reproductive health1 mentions
  47. 2026Medicinal Plants and the Gastrointestinal Microbiota in Chronic Diseases Modulation: A Structured Mechanistic and Translational Review.Current microbiology1 mentions
  48. 2026Epigenetic Alterations in Microbiome-Host Interactions in Inflammatory and Autoimmune Diseases.International journal of molecular sciences1 mentions
  49. 2026Prevalence of Fatigue Among Inflammatory Bowel Disease Patients at a Tertiary Center in Saudi Arabia.Journal of clinical medicine1 mentions
  50. 2026Adjunctive Pentoxifylline Enhances Clinical Remission and Reduces Inflammatory Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot Trial.Pharmaceuticals (Basel, Switzerland)1 mentions
  51. 2026Toward a United Arab Emirates national inflammatory bowel disease transition care pathway: Findings from a healthcare professional survey and development of evidence-based tools.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  52. 2026Silver nanoparticle-conjugated pyrimidine-based BN6 methanimine derivative improves DSS-induced inflammatory bowel disease in zebrafish.Immunopharmacology and immunotoxicology1 mentions
  53. 2026HOCl-Mediated Bromothymol Blue Bleaching and Carbon Dot Fluorescence Recovery for Fecal Myeloperoxidase Quantification in Ulcerative Colitis.Journal of fluorescence1 mentions
  54. 2026Combined acylated catalpol diglycoside and Lactobacillus therapy restores the miR-146a-TRAF6-SIRT1/AMPK signaling axis in experimental colitis.Toxicology and applied pharmacology1 mentions
  55. 2026A Review of Curcumin in Chronic Disease Management: Anti-Inflammatory Pathways, Antioxidant Activity, and Therapeutic Advances.Journal of nutrition and metabolism1 mentions
  56. 2026Prevalence, patient characteristics, and outcomes of high-dose upadacitinib in inflammatory bowel disease.Therapeutic advances in gastroenterology1 mentions
  57. 2026Oxidative Stress-Gut Microbiome Crosstalk: Intestinal Redox Imbalance and Probiotics Therapeutic Potential.Antioxidants (Basel, Switzerland)1 mentions
  58. 2026Medication Use and Guideline Adherence in Inflammatory Bowel Disease Management: A Retrospective Study from a Tertiary Care Hospital in Pakistan (2019-2024).International journal of general medicine1 mentions
  59. 2026Erratum to "The Association between Inflammatory Bowel Disease and Ischemic Heart Disease: A Retrospective Cohort Study" [Saudi Medical Journal 2025 Oct; 46(10):1174-1181].Saudi medical journal1 mentions
  60. 2026Fatigue in inflammatory bowel disease: Mechanisms, assessment, and management strategies.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  61. 2026Discordance between observer and patient-reported shared decision-making in inflammatory bowel disease: A multicenter cross-sectional study.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  62. 2026Prevalence and etiology of abnormal liver function tests in a tertiary inflammatory bowel disease cohort in the United Arab Emirates: A cross-sectional study.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  63. 2026STRIDE-II treatment target achievement in inflammatory bowel disease: a cross-sectional study from a tertiary IBD centre in the United Arab Emirates.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  64. 2026Orbital manifestations of inflammatory bowel disease - a systematic review.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie1 mentions
  65. 2026Global phenotypic similarity in inflammatory bowel disease: the Eastern Mediterranean region perspective.Journal of Crohn's & colitis1 mentions
  66. 2026Mucin armoured diethylaminoethyl-dextran cloaked rebamipide based oral nanoformulation for the therapy of inflammatory bowel disease.Materials today. Bio1 mentions
  67. 2026Association between residential greenness and the risk of inflammatory bowel disease in patients with COVID-19: A Korean nationwide cohort study.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  68. 2026Disease burden of inflammatory bowel disease and subtypes in older adults in 172 high- and middle-income countries: Trends from 2000 to 2023 and projections to 2040.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  69. 2026Non-Invasive Multimarker Strategy Combining IL-17A, Neutrophil-Albumin Ratio, and Fecal Calprotectin for Accurate Discrimination of IBD from IBS-D.International journal of molecular sciences1 mentions
  70. 2026Adherent-Invasive Escherichia coli (AIEC) in Crohn's Disease: A Bibliometric Analysis of 25 Years of Research (1999-2025).Microorganisms1 mentions
  71. 2026Patient Preferences for Virtual Versus In-Person Care in Inflammatory Bowel Disease: A Cross-Sectional Study.Telemedicine journal and e-health : the official journal of the American Telemedicine Association1 mentions
  72. 2026The relationship of apical periodontitis with chronic diseases and smoking habits: an umbrella review.Odontology1 mentions
  73. 2026Short, not skinny: The distinct sarcopenia phenotype of pediatric primary sclerosing cholangitis-inflammatory bowel disease.Journal of pediatric gastroenterology and nutrition1 mentions
  74. 2026Patient preferences toward the attributes of treatment used for inflammatory bowel disease in Saudi Arabia: Subgroup analysis from an international multicenter discrete choice experiment.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  75. 2025Ustekinumab Drug Levels and Outcomes in Inflammatory Bowel Disease.Journal of clinical gastroenterology1 mentions
  76. 2025Rates, Predictors, and Outcomes of Ustekinumab Dose Escalation in Inflammatory Bowel Disease.Journal of clinical gastroenterology1 mentions
  77. 2025Clinical effectiveness and safety of ustekinumab in youth with refractory inflammatory bowel disease: A retrospective cohort study.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  78. 2025Periodontitis increases the risk of gastrointestinal dysfunction: an update on the plausible pathogenic molecular mechanisms.Critical reviews in microbiology1 mentions
  79. 2025Bacterial metabolomics: current applications for human welfare and future aspects.Journal of Asian natural products research1 mentions
  80. 2025Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  81. 2025The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real world data from the Inflammatory Bowel Disease of the Middle East (IBD-ME) Registry group.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  82. 2025Histone Deacetylases (HDACs) Roles in Inflammation-mediated Diseases; Current Knowledge.Cell biochemistry and biophysics1 mentions
  83. 2025Corrigendum to "pH-Sensitive Tacrolimus loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease" [Eur. J. Pharm. Biopharm. 204 (2024) 114461].European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V1 mentions
  84. 2025Editorial: The safety and efficacy of ustekinumab in anti-TNF α refractory pediatric inflammatory bowel disease.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  85. 2025A bibliometric analysis of inflammatory bowel disease research in the Arab world.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  86. 2025Coexisting autoimmune disorders among patients with inflammatory bowel disease at a tertiary center in Saudi Arabia: A cross-sectional study.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  87. 2025Outcomes of Hematopoietic Stem Cell Transplantation in 5 Patients with Autosomal Recessive RIPK1-Deficiency.Journal of clinical immunology1 mentions
  88. 2025Hepatobiliary manifestations of inflammatory bowel disease in Saudi Arabia: A retrospective analysis.Saudi medical journal1 mentions
  89. 2025Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis.Therapeutic advances in gastroenterology1 mentions
  90. 2025A review on the effects of flavan-3-ols, their metabolites, and their dietary sources on gut barrier integrity.Food & function1 mentions
  91. 2025Prevalence and clinical implications of anti-drug antibody formation and serum drug levels among patients with IBD receiving anti-TNF therapy: A cross-sectional study.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  92. 2025Nutraceutical Impact of Pumpkin Seed Oil on Expression Levels of EZH-2 and KRT-14 Genes against DSS-induced Inflammatory Bowel Disease in the Rat Model.Cell biochemistry and biophysics1 mentions
  93. 2025Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres.Drugs in context1 mentions
  94. 2025Dichotomous effects of Galectin-9 in disease modulation in murine models of inflammatory bowel disease.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie1 mentions
  95. 2025Dihydroartemisinin attenuates acetic acid-induced ulcerative colitis in rats: Suppression of inflammation and modulation of NFκβ/TNF-α/RIPK1-mediated necroptosis and apoptosis.Tissue & cell1 mentions
  96. 2025Colorectal Neoplasia in Inflammatory Bowel Disease.Cancers1 mentions
  97. 2025High-Throughput Whole-Exome Sequencing and Large-Scale Computational Analysis to Identify the Genetic Biomarkers to Predict the Vedolizumab Response Status in Inflammatory Bowel Disease Patients from Saudi Arabia.Biomedicines1 mentions
  98. 2025Chloride channels and mast cell function: pioneering new frontiers in IBD therapy.Molecular and cellular biochemistry1 mentions
  99. 2025Inulin Protects Caco-2 Cells Against Lipopolysaccharide-Induced Epithelial Barrier Dysfunction.Food science & nutrition1 mentions
  100. 2025Authors' comment on: effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis.Therapeutic advances in gastroenterology1 mentions